Abstract
In recent decades, emergent diseases have caused profound frictions in democratic governance across the Atlantic. Sluggish institutional responses and inadequate treatments have escalated disputes between advocacy groups, patients, medical experts, and scientists in regulatory agencies over the speed, direction, and implications of scientific research. The arena of health politics has bec…